MS 4027 – Surgical Technique – OrthoGlide
Medial Knee ImplantRevision: L
Medial Knee Implant is intended for use in the osteoarthritic knee, where substantial amounts of cartilage have been lost as a result of the disease. The device is indicated for uncemented use in the treatment of moderate degeneration of the medial compartment of the knee (grade II-IV chondromalacia) with no more thanminimal degeneration (grade I-II chondromalacia, no loss of joint space) in the lateral and patellofemoralcompartment in patients with osteoarthritis.
Consult the ABS Package Insert (LBL 032) for additional information.
The Instructions for Use (IFU) Surgical Technique is to be used in conjunction with the ABS Package Insert (LBL032) in order to perform the ABS OrthoGlide procedure. Consult the ABS Package Insert for Warnings,Precautions, and Contraindications.
CAUTION – Federal law (U.S.A.) restricts this device to sale by or on the order of a physician.
The ABS OrthoGlide Medial Knee Implant System consists of a sterile Co-Cr implant and associated ABSinstruments needed to prepare the knee joint for implantation. The instruments consist of: a Tibial Shaper, FemoralCongruency Rasps, a Posterior Tissue Elevator, Posterior Tibial Rasp, Gap Gauges, Tibial Spine Gauge, TrialSelector, Trial Devices, Implant Inserter, Inserter Extension, Inserter Sleeve, and Extraction Device. The procedureis performed after arthroscopically inspecting the entire joint to assure the preoperative indications are verified. Themedial knee compartment is prepared for the implant by: releasing the posterior horn attachment of the medialmeniscus and then excising the medial meniscus to a 2 mm rim, contouring the medial tibial and medial femoralsurfaces using both arthroscopic and direct vision. This cartilage contouring process is monitored withflexion/extension gap measuring devices to achieve symmetrical flexion/extension spaces. The trial devices are thenused to size the tibial plateau and to evaluate the fit and function. Lastly, the implant is inserted and final fit isevaluated.
May need subsequent aspirations and corticosteroid injections if effusions occur, which is not uncommon
Time to optimal pain relief may be 6 to 12 monthsPatients should have the following radiographs taken of the operative knee within three months prior to surgery:
Anteroposterior (AP) view – weight bearing
Knee flexed 45 degrees, PA view ( Rosenberg or Skier view) - weight bearing
Merchant axial patellofemoral view
Hip to ankle alignment view In addition, an MRI may be used to aid in patient selection and evaluation especially when there is concernabout the status of the patellofemoral or lateral compartments.Pre-operative planning for each patient includes measurement of the tibial plateau on the lateral view to determinethe approximate size (AP) of the implant with correction of the degree of radiographic magnification. The indicated patient has an anatomic angular deformity of 4 degrees varus to 2 degrees valgus or as measured using themechanical axis, up to 10 degrees varus.Evaluate the pre-operative x-rays and MRI for eligibility criteria including: cartilage loss, joint space,ligament integrity, anatomic and or mechanical axis and osteophytes that could interfere with implantationand other bony or soft tissue abnormalities.
©2011 ABS Corporation Page 1 of 8/var/www/apps/conversion/current/tmp/scratch31792/106974645.doc